Cointime

Adjuvant Capital

company

About

Adjuvant Capital is a life sciences investment firm focused on global health.

  • 1 - 10

Highlights

Investments
5
Lead Investments
1

Details

Industries
Financial Services,Health Care,Venture Capital
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease.

Adjuvant Capital was founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz and is based in New York.

Investments

Number of Investments
Number of Lead Investments
5
1
Adjuvant Capital has made 5 investments. Their most recent investment was on Dec 15, 2022, when Minervax raised €22M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 15, 2022 Minervax
Series C €22M Biotechnology —
Oct 28, 2022 54gene
Convertable Note $50M Biotechnology —
Sep 16, 2021 54gene
Series B $25M Biotechnology —
Dec 15, 2020 Minervax
Series B €47.40M Biotechnology —
Apr 14, 2020 54gene
Series A $15M Biotechnology Yes
Cointime
เนื้อหา
บริษัท